Peter N. Laivins
2016
In 2016, Peter N. Laivins earned a total compensation of $947.6K as Former Head of Development at Merrimack Pharmaceuticals, a 25% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $116,796 |
|---|---|
| Option Awards | $487,110 |
| Salary | $328,106 |
| Other | $15,610 |
| Total | $947,622 |
Laivins received $487.1K in option awards, accounting for 51% of the total pay in 2016.
Laivins also received $116.8K in non-equity incentive plan, $328.1K in salary and $15.6K in other compensation.
Rankings
In 2016, Peter N. Laivins' compensation ranked 8,510th out of 14,075 executives tracked by ExecPay. In other words, Laivins earned more than 39.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,510 out of 14,075 | 40th |
Division Manufacturing | 3,269 out of 5,489 | 40th |
Major group Chemicals And Allied Products | 1,102 out of 1,895 | 42nd |
Industry group Drugs | 860 out of 1,538 | 44th |
Industry Pharmaceutical Preparations | 684 out of 1,176 | 42nd |
Source: SEC filing on June 26, 2017.
Laivins' colleagues
We found five more compensation records of executives who worked with Peter N. Laivins at Merrimack Pharmaceuticals in 2016.
2016
Robert Mulroy
Merrimack Pharmaceuticals
Chief Executive Officer
2016
Edward Stewart
Merrimack Pharmaceuticals
Former Head of Commercial
2016
William McClements
Merrimack Pharmaceuticals
Former Head of Corporate Operations
2016
Yasir Al-Wakeel
Merrimack Pharmaceuticals
Chief Financial Officer
2016
Gary Crocker
Merrimack Pharmaceuticals